Therapeutic Target-Humanized Mice
Cre/Dre-Driver Mice
Immunodeficient NMG Mice
Strain Name：MC38-hCD47-hCLDN18.2-hB7H3 Strain State ： Construction completed | Cat. NO.：NM-S13-TM71
hCD47&hCLDN18.2&hB7H3 gene humanized MC38 cell line
Strain Name：MC38-hCD47-hCLDN18.2-hB7H4 Strain State ： Construction completed | Cat. NO.：NM-S13-TM72
hCD47&hCLDN18.2&hB7H4 gene humanized MC38 cell line
Strain Name：MC38-hPD-L1/hCLAUDIN 18.2 Strain State ： Construction | Cat. NO.：NMC-230113
PD-L1 and CLAUDIN 18.2 gene humanized MC38 cell line
Strain Name：CT26-hPD-L1/hCLAUDIN 18.2 Strain State ： Construction | Cat. NO.：NMC-230112
PD-L1 and CLAUDIN 18.2 gene humanized CT26 cell line
Strain Name：MC38-hB2M/HLA-A2.1/H2-D1 Strain State ： Construction | Cat. NO.：NMC-230125
B2M/HLA-A2.1/H2-D1 gene humanized mouse cell line of MC38
Strain Name：MC38-hAFP-Tg/hB2M/HLA-A*0201/H2-D1 Strain State ： Construction | Cat. NO.：NMC-230124
AFP gene and B2M/HLA-A2.1/H2-D1 gene humanized mouse cell line of MC38
Strain Name：E.G7-OVA-hCD24 Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NM-S40-TM01
CD24 gene humanized E.G7-OVA cell line with OVA gene overexpression
Strain Name：A20-H11-hCD19-Luc Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NMC-230032
CD19 gene humanized A20 B cell line
Strain Name：A20-H11-hCD20-Luc Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NMC-230031
CD20 gene humanized A20 B cell line
Strain Name：A20-hCD22 Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NMC-230006
CD22 gene humanized A20 B cell line
Please fill in the order form and we will contact you within 2 working days.
